Tag Archive for Myriad

Innovation Is Alive And Well—R&D

As part of Patent Progress’ series on innovation in the United States, we are examining ways to measure innovation.  One useful metric, measuring the investment being made in the creation of new and innovative technologies, is research and development spending.  This metric tends to show the investment in innovation, in particular by larger companies.  And…

Roundup of This Week’s Patent News: June 14 Edition

Hi there!  No, this week wasn’t quite as eventful as last week.  (If you missed the big patent news, check out last week’s roundup.)  But we still have some news you don’t want to miss. First up, on Saturday June 8, our own Matt Levy’s Letter to the Editor was published in the New York Times, in…

Supreme Court Grants Cert in Myriad

Moments ago the United States Supreme Court granted certiorari in Assoc. for Molecular Pathology v. Myriad Genetics, Inc., et al.  (Supreme Court docket  12-398) The Court limited its grant to Question 1 presented in the petition: “are human genes patentable?” The Court did not grant certiorari as to Question 2 presented in the petition: “Did the court of appeals err in…